# Effect of Daily Glucomannan in Overweight Patients

> **NCT01485718** · PHASE4 · UNKNOWN · sponsor: **ProMedica Health System** · enrollment: 40 (estimated)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Glucomannan
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01485718
- **Lead sponsor:** ProMedica Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485718, "Effect of Daily Glucomannan in Overweight Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01485718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*